# Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/low-dose-rifaximin-prevents-complications-and-improves-survival-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xin Zeng,Xia Sheng,Peiqin Wang,Haiguang Xin,Yibin Guo,Yong Lin,Jia-Wei Zhong,Cheng-Zhi He,Jie Yin,Taotao Liu,Weijuan Ma,Xiao Xiao,Pei‐Mei Shi,Zong-Li Yuan,Ling Yang,Xiong Ma,Jianming Xu,Xizhong Shen,Changqing Yang,Xuan Zhu,Nonghua Lv,Wei‐Fen Xie |
| Citations | 39 |
| DOI | 10.1007/s12072-020-10117-y |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3115250338 |
| PMID | 33385299 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Taotao Liu](https://scholariq.org/researchers/taotao-liu/)

## Paper primary topic

- [Travel-related health issues](https://scholariq.org/topics/travel-related-health-issues/)

## Paper topics

- [Travel-related health issues](https://scholariq.org/topics/travel-related-health-issues/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.